• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Augmedix’s Device-Based Remote Scribing System Announces $19M Series B

Share:

November 4, 2019

Google glass in open gift box. 3d render isolated on white background

The company’s approach combines live medical scribes, natural language processing and either a smartphone or Google Glass device.

Augmedix, a startup that uses natural language processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and other unnamed investors all contributed.

WHAT THEY DO

Founded in 2012, the startup made a name for itself by outfitting doctors with Google Glass devices. Through these, professional medical scribes could remotely observe the visit and, with the help of NLP, fill out the patient’s necessary documentation. This approach allows the clinician to remained focused on engaging their patient, only needing to sign off on or make minor adjustments to the documentation at the end of the visit.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Since its last $23 million raise back in late 2016, Augmedix still provides customers with a device — either a Google Glass or smartphone — to support its real-time service. However, the company now boasts partnerships with 15 major health systems including Sutter Health, CommonSpirit Health and US Oncology, according to the funding announcement.

“Our service is differentiated because it operates in real-time and is enabled by natural conversation, not burdensome single-party dictation,” Manny Krakaris, CEO at Augmedix, said in a statement. “The combination of our proprietary technology and expert teams reliably delivers the highest quality medical notes thus relieving clinicians of that burden. We will continue to be at the forefront of medical documentation services by investing heavily in technology that will enable us to efficiently deliver additional services and features to our health system customers.”

WHAT IT’S FOR

Augmedix said the raise will support product developments such as automation, as well as the scaling of its service to systems and clinics across the country.

MARKET SNAPSHOT

With clinician burnout as an ever-growing threat, there are several startups that are using technology to streamline medical documentation or other time-consuming tasks.

Sopris Health has an AI tool that listens to the doctor-patient interaction, and then asks a few simple yes-no questions to the clinician afterward to compose and import a clinical note. Meanwhile IKS Health’s virtual scribe product was employed by the Massachusetts General Physicians Organization, with the group saying last year that it saved some doctors over two hours per clinical session. Others include digital assistant Suki, virtual scribe Saykara and wearable-focused Notable.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Iktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug DesignIktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug Design
  • Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio BufferAceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer
  • Australian researchers develop AI-based benchmark for measuring Alzheimer’s progressionAustralian researchers develop AI-based benchmark for measuring Alzheimer’s progression
  • How HIEs and AI can work in tandem to boost interoperability ROIHow HIEs and AI can work in tandem to boost interoperability ROI
  • Novo Nordisk Snaps Up Corvidia Therapeutics in Deal Worth Up to $2.1 BillionNovo Nordisk Snaps Up Corvidia Therapeutics in Deal Worth Up to $2.1 Billion
  • Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain EmployeesValeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees
  • Symplr to Acquire Halo HealthSymplr to Acquire Halo Health
  • CVS Hires Fitbit Executive To Lead Consumer HealthCVS Hires Fitbit Executive To Lead Consumer Health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications